CRVS - Corvus Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5117.89M
Enterprise Value 312.92M
Trailing P/E N/A
Forward P/E 1-2.05
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.17
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.28

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-22.45%
Return on Equity (ttm)-37.22%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -46.07M
Net Income Avi to Common (ttm)-44.28M
Diluted EPS (ttm)-1.5170
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)105.81M
Total Cash Per Share (mrq)3.61
Total Debt (mrq)3.77M
Total Debt/Equity (mrq)3.74
Current Ratio (mrq)12.39
Book Value Per Share (mrq)3.43

Cash Flow Statement

Operating Cash Flow (ttm)-38.93M
Levered Free Cash Flow (ttm)-24.29M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.02
52-Week Change 3-63.61%
S&P500 52-Week Change 35.14%
52 Week High 313.9100
52 Week Low 33.2200
50-Day Moving Average 34.1117
200-Day Moving Average 34.6636

Share Statistics

Avg Vol (3 month) 383.2k
Avg Vol (10 day) 356k
Shares Outstanding 529.33M
Float 11.72M
% Held by Insiders 15.09%
% Held by Institutions 186.18%
Shares Short (Apr 30, 2019) 41.48M
Short Ratio (Apr 30, 2019) 419.98
Short % of Float (Apr 30, 2019) 410.68%
Short % of Shares Outstanding (Apr 30, 2019) 45.04%
Shares Short (prior month Mar 29, 2019) 41.37M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A